CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 4 Planned sale President and CEO sold 1,332 shares at $5.81 ($7,739)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 17,808 shares at $5.13 ($91,355)
- 4 Planned sale Chief Financial Officer sold 4,135 shares at an average $5.13 ($21,202)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 335 shares at $5.65 ($1,893)
- 4 Open-market sale Director sold 284 shares at $5.65 ($1,605)
- 4 Open-market sale Director sold 594 shares at $5.65 ($3,356)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
Page 7 of 53 · 1,058 filings